Francesca Borrelli. Show Affiliations »
Abstract
Mesh: See more » AnimalsBenzoxazines/pharmacologyBiomarkers/metabolismCalcium Channel Blockers/pharmacologyEnzyme Inhibitors/pharmacologyGastric Acid/metabolismGastric Mucosa/metabolismMorpholines/pharmacologyNaphthalenes/pharmacologyOuabain/pharmacologyPiperidines/pharmacologyPyrazoles/pharmacologyRatsReceptor, Cannabinoid, CB1/agonistsReceptor, Cannabinoid, CB1/antagonists & inhibitorsReceptor, Cannabinoid, CB1/metabolismRimonabantStomach/drug effects
Substances: See more » BenzoxazinesBiomarkersCalcium Channel BlockersEnzyme InhibitorsMorpholinesNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1Ouabain(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneRimonabant
Year: 2007 PMID: 17404883 DOI: 10.1007/s10620-006-9507-4
Source DB: PubMed Journal: Dig Dis Sci ISSN: 0163-2116 Impact factor: 3.199